We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARA
2776
DELISTED
American Renal Associates Holdings, Inc
ARA
$7K ﹤0.01%
409
-291
-42% -$4.02K
MBTF
2777
DELISTED
MBT Financial Corporation
MBTF
$7K ﹤0.01%
671
-59
-8% -$629
PHH
2778
DELISTED
PHH Corporation
PHH
$7K ﹤0.01%
698
-4,871
-87% -$59.2K
YUME
2779
DELISTED
YuMe, Inc.
YUME
$7K ﹤0.01%
1,563
-3,175
-67% -$12.6K
ARC
2780
DELISTED
ARC Document Solutions, Inc.
ARC
$7K ﹤0.01%
2,734
+1,644
+151% +$5.42K
YELL
2781
DELISTED
Yellow Corporation Common Stock
YELL
$7K ﹤0.01%
492
-6,611
-93% -$87.1K
DFVL
2782
DELISTED
iPath US Treasury 5-year Bull ETN
DFVL
$7K ﹤0.01%
114
HYND
2783
DELISTED
WisdomTree Trust WisdomTree WisdomTree Negative Duration High Yield Bond Fund
HYND
$7K ﹤0.01%
341
-55
-14% -$1.14K
ARLZ
2784
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$7K ﹤0.01%
4,916
+3,516
+251% +$5.77K
FAC
2785
DELISTED
First Acceptance Corp.
FAC
$7K ﹤0.01%
+5,858
New +$6.9K
BSQR
2786
DELISTED
BSQUARE Corporation
BSQR
$7K ﹤0.01%
1,504
-1,019
-40% -$5K
AEG icon
2787
Aegon
AEG
$14.1B
$6K ﹤0.01%
1,230
-10,128
-89% -$49.4K
AGRO icon
2788
Adecoagro
AGRO
$1.36B
$6K ﹤0.01%
570
-1,739
-75% -$17.5K
AMC icon
2789
AMC Entertainment Holdings
AMC
$2.39B
$6K ﹤0.01%
40
+36
+900% +$5.05K
ANDE icon
2790
Andersons Inc
ANDE
$2.38B
$6K ﹤0.01%
207
-3,656
-95% -$122K
APVO icon
2791
Aptevo Therapeutics
APVO
$5.22M
0
APYX icon
2792
Apyx Medical
APYX
$174M
$6K ﹤0.01%
+2,265
New +$7.07K
ASHR icon
2793
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
$6K ﹤0.01%
+200
New +$6.13K
AZUL
2794
DELISTED
Azul
AZUL
$6K ﹤0.01%
+267
New +$6.82K
BAND
2795
Bandwidth Inc
BAND
$1.45B
$6K ﹤0.01%
+238
New +$5.13K
BCLI
2796
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$6K ﹤0.01%
100
-19
-16% -$1.14K
BX icon
2797
Blackstone
BX
$109B
$6K ﹤0.01%
200
+191
+2,122% +$6.22K
CENTA icon
2798
Central Garden & Pet Co Class A
CENTA
$2.45B
$6K ﹤0.01%
198
-4,081
-95% -$121K
CIO
2799
DELISTED
City Office REIT
CIO
$6K ﹤0.01%
449
-1,548
-78% -$20.3K
CLH icon
2800
Clean Harbors
CLH
$16.4B
$6K ﹤0.01%
+115
New +$6.23K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.